Hjem › Skleroserende cholangitis › Pennsylvania
Skleroserende cholangitis kliniske forsøg i Pennsylvania
3 studier for Skleroserende cholangitis søger deltagere på steder i Pennsylvania.
Officiel studietekst (engelsk)
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
- Penn State Milton S.Hershey Medical Center - Penn State Hershey Cancer Institute, Hershey
- University of Pennsylvania - Perelman Center for Advanced Medicine, Philadelphia
- Thomas Jefferson University Hospital - Jefferson Digestive Disease Institute (JDDI), Philadelphia
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 1. okt. 2026 · NCT07387549A-LiNK: Improving Outcomes in Autoimmune Liver Disease
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 19. aug. 2026 · NCT05750498Primary Sclerosing Cholangitis in Children
- The Children's Hospital of Philadelphia, Philadelphia
RekruttererObservationsstudie
Alder 2 til 25 · Alle køn · Opdateret 14. jul. 2026 · NCT04181138Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.